Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2016 - 2025)

Amphastar Pharmaceuticals has reported Free Cash Flow over the past 13 years, most recently at $31.6 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $31.6 million for Q4 2025, up 90.51% from a year ago — trailing twelve months through Dec 2025 was $148.4 million (down 13.91% YoY), and the annual figure for FY2025 was $148.4 million, down 13.91%.
  • Free Cash Flow for Q4 2025 was $31.6 million at Amphastar Pharmaceuticals, down from $52.1 million in the prior quarter.
  • Over the last five years, Free Cash Flow for AMPH hit a ceiling of $63.5 million in Q3 2023 and a floor of -$9.8 million in Q4 2023.
  • Median Free Cash Flow over the past 5 years was $33.6 million (2023), compared with a mean of $31.0 million.
  • Biggest five-year swings in Free Cash Flow: tumbled 246.41% in 2021 and later soared 2274.78% in 2023.
  • Amphastar Pharmaceuticals' Free Cash Flow stood at $51.5 million in 2021, then plummeted by 110.43% to -$5.4 million in 2022, then tumbled by 82.37% to -$9.8 million in 2023, then soared by 269.42% to $16.6 million in 2024, then skyrocketed by 90.51% to $31.6 million in 2025.
  • The last three reported values for Free Cash Flow were $31.6 million (Q4 2025), $52.1 million (Q3 2025), and $40.2 million (Q2 2025) per Business Quant data.